✦ LIBER ✦

Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer? -A prospective clinical study

✍ Scribed by Chintamani; Vinay Singhal; JP Singh; Ashima Lyall; Sunita Saxena; Anju Bansal

Book ID: 115010577
Publisher: BioMed Central
Year: 2004
Tongue: English
Weight: 704 KB
Volume: 4
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-4-48

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P339 The correlation of anxiety and depr

P339 The correlation of anxiety and depression levels with response to neo-adjuvant chemotherapy in patients with breast cancer – A prospective study

✍ Chintamani; A. Gogne; R. Khandewal; M. Tandon; U. Agarwal; S. Saxena 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Responses to chemotherapy or chemohormon

Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy: A subset analysis of CALGB study 8081

✍ Carl G. Kardinal; Michael C. Perry; Ann H. Korzun; Mary Alice Rice; Sandra Ginsb 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 2 views

The Cancer and Leukemia Group B (CALGB) evaluated the response to subsequent chemotherapy or chemohormonal therapy in 46 patients with advanced breast cancer treated previously with adjuvant chemotherapy that had been completed 6 months or more before protocol entry. The results were compared with 3

5BA Clinical validation of in vitro drug

5BA Clinical validation of in vitro drug sensitivity microarray data: regimen-specific signatures predict pathological complete response to neo-adjuvant chemotherapy for breast cancer in a randomized trial (EORTC 10994/BIG 00-01)

✍ H. Bonnefoi; A. Potti; L. Mauriac; M. Tubiana-Hulin; M. Campone; D. Cameron; J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views